SCHEMBL9681001

SCHEMBL9681001

Cc1cccc(N)c1-c1ccc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.53
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
SRC P12931 2/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
AR P10275 1/20 0.42
MAPT P10636 1/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42
GFER P55789 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9319110 0.90 CYP1A2 (0.52) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL1133131 0.88 IKBKB (0.54) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL35312 0.82 CYP1A2 (0.52) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL25011940 0.82 CD44 (0.54) CYP1A2CYP3A4TDP1SRCALDH1A1
SCHEMBL3358215 0.80 ALOX5 (0.52) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL2934548 0.80 ALOX5 (0.52) IKBKBCYP1A2CYP3A4HSD17B1HSD17B2
SCHEMBL6662389 0.79 IKBKB (0.46) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL28441429 0.77 ERN1 (0.50) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL27834726 0.76 GSTP1 (0.48) IKBKBCYP1A2CYP3A4TDP1HSD17B1
SCHEMBL1133224 0.76 CYP2A6 (0.54) IKBKBCYP1A2CYP3A4TDP1HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed